Can self vaginal douching for high risk HPV screening replace or assist efficacy of cervical cancer screening?
- PMID: 21198300
Can self vaginal douching for high risk HPV screening replace or assist efficacy of cervical cancer screening?
Abstract
Objective: To study the accuracy of self vaginal douching and collection for HPV types 16, 18, 31 and 33 in women visiting Thammasat Hospital for the explicit purpose of cervical screening.
Methods: A pelvic examination and Pap smear were performed for all women who came for cervical screening. Specimens were also collected by self vaginal douching before cervical screening and sent to the cell and molecular biology laboratory for analysis of human papillomavirus (HPV) types 16, 18, 31 and 33 using the polymerase chain reaction (PCR).
Results: HPV prevalence was 3.6% overall from 250 women in this study. Twenty-four (9.6%) women had an abnormal cytology screening result. No cancer was found. Four women had a high grade squamous intraepithelial lesion (HSIL) and 14 had a low grade squamous intraepithelial lesion (LSIL) from colposcopic biopsy. Self vaginal douching for HPV 16, 18, 31 and 33 was used to predict abnormal Pap smear. Sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) were 12.5%, 97.5%, 33.3% and 91.3%, respectively.
Conclusion: From our analysis of self-vaginal douching for HPV detection using cases from Thammasat university hospital, it cannot replace the Pap smear.
Similar articles
-
[Clinical efficacy of HPV DNA chip test in the era of HPV vaccination: 1,211 cases, a single institution study].Korean J Lab Med. 2008 Feb;28(1):70-8. doi: 10.3343/kjlm.2008.28.1.70. Korean J Lab Med. 2008. PMID: 18309258 Korean.
-
Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.BJOG. 2004 Aug;111(8):842-8. doi: 10.1111/j.1471-0528.2004.00210.x. BJOG. 2004. PMID: 15270934
-
The prevelance of human papillomavirus (HPV) genotypes detected by PCR in women with normal and abnormal cervico-vaginal cytology.Ginekol Pol. 2018;89(2):62-67. doi: 10.5603/GP.a2018.0011. Ginekol Pol. 2018. PMID: 29512809
-
Cervical cancer screening from Pap smear to human papillomavirus DNA testing.Compr Ther. 2001 Fall;27(3):202-8. doi: 10.1007/s12019-001-0015-3. Compr Ther. 2001. PMID: 11569320 Review.
-
Molecular detection of human papillomavirus from abnormal cervical cytology of women attending a tertiary health facility in Ido-ekiti, southwest Nigeria.J Prev Med Hyg. 2016;57(2):E86-90. J Prev Med Hyg. 2016. PMID: 27582634 Free PMC article. Review.